Cosmos Health - 15 Year Stock Price History | COSM

Historical daily share price chart and data for Cosmos Health since 2010 adjusted for splits and dividends. The latest closing stock price for Cosmos Health as of August 28, 2025 is 0.83.
  • The all-time high Cosmos Health stock closing price was 337.50 on March 13, 2014.
  • The Cosmos Health 52-week high stock price is 1.28, which is 54.2% above the current share price.
  • The Cosmos Health 52-week low stock price is 0.28, which is 66.3% below the current share price.
  • The average Cosmos Health stock price for the last 52 weeks is 0.65.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cosmos Health Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.5634 0.6860 1.1500 0.3176 0.8288 23.89%
2024 0.8623 1.3700 1.4600 0.4838 0.6690 -52.55%
2023 2.6324 5.5200 6.8200 0.9900 1.4100 -69.08%
2022 29.4652 95.0000 96.0000 1.8250 4.5600 -94.59%
2021 120.6560 127.5000 192.2500 72.5000 84.2500 -33.92%
2020 75.1304 59.7500 137.2500 28.7500 127.5000 131.82%
2019 77.4871 93.0000 98.7500 55.0000 55.0000 -45.00%
2018 180.4698 270.0000 312.5000 75.0000 100.0000 -60.78%
2017 180.6304 205.0000 266.2500 110.0000 255.0000 24.39%
2016 154.1082 171.2500 205.0000 87.7750 205.0000 2.50%
2015 179.1815 225.0000 235.0000 102.5000 200.0000 -9.09%
2014 268.2806 322.5000 337.5000 217.5000 220.0000 -27.87%
2013 163.9382 62.5000 335.0000 37.5000 305.0000 577.78%
2012 58.7500 62.5000 127.5000 20.0000 45.0000 -64.71%
2011 163.7391 112.5000 300.0000 52.5000 127.5000 -49.50%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.024B $0.054B
Cosmos Health is a healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices. Cosmos Health, formerly known as Cosmos Holdings Inc., is based in CHICAGO, IL.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $71.053B 27.33
Zoetis (ZTS) United States $68.857B 24.98
Takeda Pharmaceutical (TAK) Japan $47.283B 9.65
Daiichi Sankyo, - (DSNKY) Japan $45.957B 23.55
BeOne Medicines - (ONC) Switzerland $32.895B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.654B 0.00
Summit Therapeutics (SMMT) United States $18.426B 0.00
Merck (MKKGY) Germany $16.343B 10.63
Shionogi (SGIOY) Japan $14.666B 14.69
United Therapeutics (UTHR) United States $13.773B 11.92
Neurocrine Biosciences (NBIX) United States $13.700B 40.87
Orion OYJ (ORINY) Finland $11.244B 27.10
IPSEN (IPSEY) France $11.184B 0.00
Madrigal Pharmaceuticals (MDGL) United States $9.438B 0.00
Eisai (ESAIY) $9.099B 10.26
Corcept Therapeutics (CORT) United States $7.348B 61.71
Ionis Pharmaceuticals (IONS) United States $6.814B 0.00
Stevanato Group S.p.A (STVN) Italy $6.784B 40.00
Grifols, S.A (GRFS) Spain $6.738B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.597B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.940B 13.97
Crinetics Pharmaceuticals (CRNX) United States $2.863B 0.00
Hypermarcas (HYPMY) Brazil $2.831B 21.29
Procaps Group, S.A (PROCF) Luxembourg $2.799B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.756B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.471B 8.27
Centessa Pharmaceuticals (CNTA) United Kingdom $2.230B 0.00
Ocular Therapeutix (OCUL) United States $2.144B 0.00
Dyne Therapeutics (DYN) United States $1.940B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
Guardian Pharmacy Services (GRDN) United States $1.631B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.594B 23.75
Ardelyx (ARDX) United States $1.492B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.444B 0.00
Harrow (HROW) United States $1.435B 0.00
ARS Pharmaceuticals (SPRY) United States $1.328B 0.00
Xeris Biopharma Holdings (XERS) United States $1.290B 0.00
Evotec AG (EVO) Germany $1.239B 0.00
Enliven Therapeutics (ELVN) United States $1.225B 0.00
Collegium Pharmaceutical (COLL) United States $1.222B 6.68
Cronos Group (CRON) Canada $0.981B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.843B 0.00
Akebia Therapeutics (AKBA) United States $0.798B 0.00
ProKidney (PROK) United States $0.733B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.713B 7.34
Theravance Biopharma (TBPH) United States $0.695B 57.50
KalVista Pharmaceuticals (KALV) United States $0.684B 0.00
Bioventus (BVS) United States $0.619B 14.98
Relay Therapeutics (RLAY) United States $0.616B 0.00
Organogenesis (ORGO) United States $0.614B 0.00
Elite Pharmaceuticals (ELTP) United States $0.610B 0.00
Tourmaline Bio (TRML) United States $0.604B 0.00
Siga Technologies (SIGA) United States $0.591B 7.30
USANA Health Sciences (USNA) United States $0.587B 12.03
Xencor (XNCR) United States $0.572B 0.00
Savara (SVRA) United States $0.569B 0.00
Oruka Therapeutics (ORKA) United States $0.569B 0.00
Nektar Therapeutics (NKTR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.525B 0.00
Esperion Therapeutics (ESPR) United States $0.440B 0.00
Nanobiotix S.A (NBTX) France $0.431B 0.00
Aquestive Therapeutics (AQST) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.350B 0.00
Altimmune (ALT) United States $0.324B 0.00
Larimar Therapeutics (LRMR) United States $0.323B 0.00
4D Molecular Therapeutics (FDMT) United States $0.302B 0.00
Nature's Sunshine Products (NATR) United States $0.298B 19.40
AleAnna (ANNA) United States $0.283B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.282B 0.00
Lexeo Therapeutics (LXEO) United States $0.262B 0.00
Galectin Therapeutics (GALT) United States $0.255B 0.00
Lyell Immunopharma (LYEL) United States $0.217B 0.00
Heron Therapeutics (HRTX) United States $0.208B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.205B 31.50
Korro Bio (KRRO) United States $0.203B 0.00
OmniAb (OABI) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.197B 0.00
MediWound (MDWD) Israel $0.184B 0.00
Journey Medical (DERM) United States $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) China $0.172B 0.00
MEI Pharma (MEIP) United States $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.133B 0.00
Wellgistics Health (WGRX) United States $0.130B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Avalo Therapeutics (AVTX) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Cassava Sciences (SAVA) United States $0.112B 0.00
Dominari Holdings (DOMH) United States $0.100B 0.00
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 20.62
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Liminatus Pharma (LIMN) United States $0.079B 0.00
Context Therapeutics (CNTX) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Prelude Therapeutics (PRLD) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Karyopharm Therapeutics (KPTI) United States $0.068B 0.00
Gain Therapeutics (GANX) United States $0.067B 0.00
Inotiv (NOTV) United States $0.060B 0.00
DURECT (DRRX) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Rafael Holdings (RFL) United States $0.053B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.91
Fractyl Health (GUTS) United States $0.050B 0.00
Plus Therapeutics (PSTV) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Tempest Therapeutics (TPST) United States $0.048B 0.00
Klotho Neurosciences (KLTO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.043B 0.00
FibroGen (FGEN) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.021B 0.00
Incannex Healthcare (IXHL) Australia $0.020B 0.00
Ainos (AIMD) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
ESSA Pharma (EPIX) Canada $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Vyome Holdings (HIND) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.69
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.60
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00